Archives
-
Biotin-16-UTP for RNA Labeling Workflows
2026-09-15
Biotin-16-UTP enables affinity-ready RNA for detection, purification, localization, and RNA–protein studies without genetically modifying the target protein. This practical guide connects controlled in vitro transcription RNA labeling with assay design lessons from a recent endogenous-protein biosensor study.
-
Carbapenemase Transmission in Enterobacter cloacae
2026-09-14
A 2025 BMC Microbiology study mapped carbapenemase-encoding genes, mobile elements, and strain relatedness among carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. Its findings connect plasmid-associated blaNDM-1 with multidrug resistance and efficient conjugative transfer, while ERIC-PCR indicates concurrent clonal dissemination across clinical settings.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-14
CAY10499 enables controlled interrogation of HSL, MGL, and FAAH activity in biochemical, lipid-flux, and macrophage immunometabolism workflows. Its value in extracellular vesicle-driven tumor studies is complementary to ACLY inhibition: it tests downstream lipid handling without being presented as a direct ACLY inhibitor.
-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-09-13
The reference study identifies Munc18c as a functional regulator of syntaxin4 during invadopodium formation, linking SNARE control to the trafficking of MT1-MMP and EGFR. Its peptide-competition and loss-of-function experiments show how disrupting the Munc18c–syntaxin4 axis reduces extracellular matrix invasion in tumor cells.
-
PARP1–FAK–COL5A1 Signaling in Ovarian Cancer
2026-09-12
The reference study establishes a cholesterol-resistant ovarian cancer model and identifies a PARP1–FAK/Src–COL5A1 axis that promotes epithelial–mesenchymal transition and tumorigenesis. Its design links chronic metabolic stress to adhesion-associated signaling, providing a mechanistic framework for cancer biology research and pathway-focused intervention studies.
-
Citrate Molarity Shapes mRNA-LNP Function
2026-09-11
The reference study shows that citrate buffer molarity can alter mRNA-LNP internalization and transfection even when conventional measurements such as average particle size, polydispersity, and encapsulation efficiency appear comparable. Its findings support treating buffer composition as a critical process variable and pairing routine quality attributes with morphology, uptake, potency, and in vivo expression analyses.
-
GW 6471: Causal PPARα Assay Design
2026-09-11
GW 6471 is a mechanistically defined PPARα antagonist for separating pathway association from causality. This article translates PFHxS zebrafish evidence into rigorous assay-design decisions for cellular metabolism research, lipid homeostasis studies, and related disease models.
-
CTP Solution (100 mM) for RNA Synthesis
2026-09-10
CTP Solution is an aqueous Cytidine-5'-triphosphate reagent for RNA synthesis, in vitro transcription, and related biochemical workflows. The K1045 formulation provides ≥99% HPLC-purity CTP at 100 mM and is designed for sensitive reactions that require controlled pH and low nuclease or phosphatase contamination.
-
Alternariol Drives LX-2 Fibrotic Reprogramming
2026-09-10
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can convert LX-2 hepatic stellate cells toward a contractile, extracellular-matrix-producing myofibroblast phenotype, whereas tenuazonic acid showed no significant effect in the tested model. By integrating lncRNA–mRNA omics with pathway analysis and a CotA laccase detoxification strategy, the work connects emerging Alternaria toxins with hepatic fibrotic signaling.
-
EDC.HCl Coupling Workflow Guide
2026-09-09
EDC.HCl is a water-soluble carbodiimide for activating carboxyl groups before amide bond formation with primary amines in controlled laboratory workflows. It is suitable for in vitro peptide synthesis, bioconjugation, and related coupling applications, but no in vivo or clinical data are available for this reagent.
-
Metformin Hydrochloride: Reliable Assay Design
2026-09-09
A scenario-driven guide to using Metformin Hydrochloride (Metformin HCl), SKU B1970, in viability, proliferation, cytotoxicity, and AMPK-focused experiments. It connects formulation choices with assay interpretation and literature-supported metabolic and antifibrotic models.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-08
This open-access FASEB Journal study developed lipid nanoparticles carrying chemically modified p21 mRNA for localized intravesical tumor suppressor replacement. Across molecular, cellular, biodistribution, and orthotopic mouse experiments, the approach restored nuclear p21, restrained bladder tumor growth, and limited systemic exposure, while leaving important clinical and formulation questions unresolved.
-
ddhCTP: Designing Mechanism-Resolved Antiviral Assays
2026-09-08
ddhCTP is more than a chain-terminating antiviral nucleotide analog: it is a mechanistic probe for separating direct RdRp inhibition from broader viperin-mediated effects. This guide develops an evidence-resolved assay strategy for flavivirus research, coronavirus interpretation, and antiviral drug development.
-
APEX2–TERT Regulation in Human Embryonic Stem Cells
2026-09-07
A 2024 preprint identifies APEX2 as a previously unrecognized regulator of efficient TERT expression in human embryonic stem cells, distinguishing its role from the related repair enzyme APEX1. Knockdown, RNA-seq, telomerase assays, and chromatin immunoprecipitation connect APEX2 activity with repeat-rich regions, especially MIR sequences within TERT intron 2.
-
Müller Cell PEDF–Angiopoietin Control of Retinal Survival
2026-09-07
Younis and colleagues identify Müller cell-derived pigment epithelium-derived factor as a mechanistic link between angiopoietin signaling and retinal neuron survival. Their co-culture, knockdown, hypoxia, and rescue experiments position Ang-1 as supportive of a Tie-2–PI3K/Akt–PEDF pathway, while Ang-2 weakens this neuroprotective axis.